ライブ
AgilentBoston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeatThermo FisherTMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Borrow Rate - Xã Thanh HàAgilentIs Agilent Technologies a Better Buy Than Danaher? - TrefisLonza NewsIs Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings? - Yahoo FinanceThermo FisherTMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải PhòngFierceBiotechLilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitorsThermo FisherThermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.comWatersWAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn LaFierceBiotechMcKesson swaps minority stake in surgical unit to Apollo Funds for $1.25BFierceBiotechAcuityMD raises $80M to help bolster AI in the medtech industryFierceBiotechAACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’FierceBiotechMerck goes with Google for AI push, striking enterprise partnership worth up to $1B
FierceBiotech 2026年1月12日

AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF bispecific battle

AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF bispecific battle

原文
本文は利用できません。元の情報源をご確認ください。